Risk Management and Financial Instruments - Governance
The main risks to which the Company and its subsidiaries are exposed reflect strategic/operational and economic/financial aspects. Operational/strategic risks (including, but not limited to, demand behavior, competition, technological innovation, and material changes in the industry structure) are addressed by the Company’s management model. Economic/financial risks primarily reflect default of customers, behavior of macroeconomic variables, such as exchange and interest rates, as well as the characteristics of the financial instruments used by the Company and its subsidiaries and their counterparties. These risks are managed through control policies, specific strategies, and the establishment of limits.
The Company has a policy for the management of resources, financial instruments, and risks approved by its Board of Directors (“Policy”). In accordance with the Policy, the main objectives of financial management are to preserve the value and liquidity of financial assets and ensure financial resources for the development of the business, including expansions. The main financial risks considered in the Policy are risks associated with currencies, interest rates, credit, and selection of financial instruments. Governance of the management of financial risks and financial instruments follows the segregation of duties below:
• | Implementation of the management of financial assets, instruments, and risks is the responsibility of the financial area, through its treasury department, with the assistance of the tax and accounting departments. | |
• | Supervision and monitoring of compliance with the principles, guidelines, and standards of the Policy is the responsibility of the Risk and Investment Committee, which is composed of members of the Company’s Executive Board (“Committee”). The Committee holds regular meetings and is in charge, among other responsibilities, of discussing and monitoring the financial strategies, existing exposures, and significant transactions involving investment, fundraising, or risk mitigation. The Committee monitors the risk standards established by the Policy through a monitoring map on a monthly basis. | |
• | Changes in the Policy or revisions of its standards are subject to the approval of the Board of Directors of Ultrapar. | |
• | Continuous improvement of the Policy is the joint responsibility of the Board of Directors, the Committee, and the financial area. | |
• | The internal audit department audits the compliance with the requirements of the Policy. |
Currency Risk
Most transactions of the Company, through its subsidiaries, are located in Brazil and, therefore, the reference currency for risk management is the Brazilian Real. Currency risk management is guided by neutrality of currency exposures and considers the transactional, accounting, and operational risks of the Company and its subsidiaries and their exposure to changes in exchange rates. The Company considers as its main currency exposures the assets and liabilities in foreign currency and the short-term flow of net sales in foreign currency of Oxiteno.
The Company and its subsidiaries use exchange rate hedging instruments (especially between the Brazilian Real and the U.S. dollar) available in the financial market to protect their assets, liabilities, receipts, and disbursements in foreign currency and net investments in foreign operations. Hedge is used in order to reduce the effects of changes in exchange rates on the Company´s income and cash flows in Brazilian Reais within the exposure limits under its Policy. Such foreign exchange hedging instruments have amounts, periods, and rates substantially equivalent to those of assets, liabilities, receipts, and disbursements in foreign currencies to which they are related. Assets and liabilities in foreign currencies are stated below, translated into Brazilian Reais:
Assets and Liabilities in Foreign Currencies
In millions of Brazilian Reais | 2017 | 2016 | ||
Assets in foreign currency | ||||
Cash, cash equivalents and financial investments in foreign currency (except hedging instruments) | 236.4 | 423.9 | ||
Foreign trade receivables, net of allowance for doubtful accounts and advances to foreign customers | 214.9 | 323.4 | ||
Net investments in foreign subsidiaries (except cash, cash equivalents, financial investments, trade receivables, financing, and payables) | 930.0 | 600.9 | ||
1,381.3 | 1,348.2 | |||
Liabilities in foreign currency | ||||
Financing in foreign currency, gross of transaction costs and discount | (4,416.2) | (4,736.3) | ||
Payables arising from imports, net of advances to foreign suppliers | (173,1) | (57.1) | ||
(4,589.3) | (4,793.4) | |||
Foreign currency hedging instruments | 1,777.6 | 2,206.4 | ||
Net asset (liability) position – Total | (1,430.4) | (1,238.8) | ||
Net asset (liability) position – Income statement effect | (26.1) | 24.8 | ||
Net asset (liability) position – Shareholders’ equity effect | (1,404.3) | (1,263.6) |
Sensitivity Analysis of Assets and Liabilities in Foreign Currency
The table below shows the effect of exchange rate changes in different scenarios, based on the net liability position of R$ 1,430.4 million in foreign currency:
In millions of Brazilian Reais | Risk | Scenario I | Scenario II | Scenario III | |||
10% | 25% | 50% | |||||
(1) Income statement effect | Real devaluation | (2.6) | (6.5) | (13.0) | |||
(2) Shareholders’ equity effect | (140.4) | (351.1) | (702.2) | ||||
(1) + (2) | Net effect | (143.0) | (357.6) | (715.2) | |||
(3) Income statement effect | Real appreciation | 2.6 | 6.5 | 13.0 | |||
(4) Shareholders’ equity effect | 140.4 | 351.1 | 702.2 | ||||
(3) + (4) | Net effect | 143.0 | 357.6 | 715.2 |
The shareholders’ equity effect refers to cumulative translation adjustments of changes in the exchange rate on equity of foreign subsidiaries (see Notes 2.r and 23.g - Cumulative Translation Adjustments), net investments hedge in foreign entities, cash flow hedge of firm commitment and highly probable transaction (see Note 2.c and Hedge Accounting below).
Interest Rate Risk
The Company and its subsidiaries adopt policies for borrowing and investing financial resources and for capital cost minimization. The financial investments of the Company and its subsidiaries are primarily held in transactions linked to the CDI, as set forth in Note 4. Borrowings primarily relate to financing from Banco do Brasil, BNDES, and other development agencies, as well as debentures and borrowings in foreign currency, as shown in Note 14.
The Company attempts to maintain its financial interest assets and liabilities at floating rates.
The table below shows the financial assets and liabilities exposed to floating interest rates:
In millions of Brazilian Reais
Note | 2017 | 2016 | |||
CDI | |||||
Cash equivalents | 4 | 4,821.6 | 3,837.8 | ||
Financial investments | 4 | 1,153.0 | 1,174.5 | ||
Asset position of foreign exchange hedging instruments - CDI | 31 | 29.9 | 28.3 | ||
Loans and debentures | 14 | (7,987.3) | (5,862.3) | ||
Liability position of foreign exchange hedging instruments - CDI | 31 | (1,877.4) | (2,181.6) | ||
Liability position of fixed interest instruments - CDI | 31 | (586.6) | - | ||
Net liability position in CDI | (4,446.8) | (3,003.3) | |||
TJLP | |||||
Loans –TJLP | 14 | (301.9) | (404.4) | ||
Net liability position in TJLP | (301.9) | (404.4) | |||
LIBOR | |||||
Asset position of foreign exchange hedging instruments - LIBOR | 31 | 984.3 | 1,149.7 | ||
Loans - LIBOR | 14 | (1,418.5) | (1,470.1) | ||
Net liability position in LIBOR | (434.2) | (320.4) | |||
TIIE | |||||
Loans - TIIE | 14 | (3.4) | (9.6) | ||
Net liability position in TIIE | (3.4) | (9.6) | |||
SELIC | |||||
Loans – SELIC | 14 | (100.3) | (99.5) | ||
Net liability position in SELIC | (100.3) | (99.5) | |||
Total net liability position exposed to floating interest | (5,286.6) | (3,837.2) |
Sensitivity Analysis of Floating Interest Rate Risk
The table below shows the incremental expenses and income that would be recognized in financial income in 2017, due to the effect of floating interest rate changes in different scenarios.
For sensitivity analysis of floating interest rate risk, the Company used the accumulated amount of the reference indexes (CDI, TJLP, LIBOR, TIIE and SELIC) as a base scenario up to December 31, 2017. Scenarios I, II and III were based on of 10%, 25% and 50% variation, respectively, in the floating interest rate of the base scenario:
In millions of Brazilian Reais | |||||||
Risk | Scenario I | Scenario II | Scenario III | ||||
10% | 25% | 50% | |||||
Exposure of interest rate risk | |||||||
Interest effect on cash equivalents and financial investments | Increase in CDI | 47.3 | 118.1 | 236.3 | |||
Foreign exchange hedging instruments (assets in CDI) effect | Increase in CDI | 0.2 | 0.5 | 1.0 | |||
Interest effect on debt in CDI | Increase in CDI | (67.2) | (168.0) | (336.0) | |||
Interest rate hedging instruments (liabilities in CDI) effect | Increase in CDI | (38.6) | (94.2) | (186.7) | |||
Incremental expenses | (58.3) | (143.6) | (285.4) | ||||
Interest effect on debt in TJLP | Increase in TJLP | (2.3) | (5.6) | (11.3) | |||
Incremental expenses | (2.3) | (5.6) | (11.3) | ||||
Foreign exchange hedging instruments (assets in LIBOR) effect | Increase in LIBOR | 1.4 | 3.4 | 6.8 | |||
Interest effect on debt in LIBOR | Increase in LIBOR | (1.7) | (4.4) | (8.7) | |||
Incremental expenses | (0.3) | (1.0) | (1.9) | ||||
Interest effect on debt in TIIE | Increase in TIIE | (0.0) | (0.1) | (0.2) | |||
Incremental expenses | (0.0) | (0.1) | (0.2) | ||||
Interest effect on debt in SELIC | Increase in SELIC | (1.0) | (2.5) | (4.9) | |||
Incremental expenses | (1.0) | (2.5) | (4.9) |
Credit Risks
The financial instruments that would expose the Company and its subsidiaries to credit risks of the counterparty are basically represented by cash and bank deposits, financial investments, hedging instruments (see Note 4), and trade receivables (see Note 5).
Credit risk of financial institutions - Such risk results from the inability of financial institutions to comply with their financial obligations to the Company and its subsidiaries due to insolvency. The Company and its subsidiaries regularly conduct a credit review of the institutions with which they hold cash and cash equivalents, financial investments, and hedging instruments through various methodologies that assess liquidity, solvency, leverage, portfolio quality, etc. Cash and cash equivalents, financial investments, and hedging instruments are held only with institutions with a solid credit history, chosen for safety and soundness. The volume of cash and cash equivalents, financial investments, and hedging instruments are subject to maximum limits by each institution and, therefore, require diversification of counterparties.
Government credit risk - The Company's policy allows investments in government securities from countries classified as investment grade AAA or Aaa by specialized credit rating agencies and in Brazilian government bonds. The volume of such financial investments is subject to maximum limits by each country and, therefore, requires diversification of counterparties.
Customer credit risk - Such risks are managed by each business unit through specific criteria for acceptance of customers and their credit rating and are additionally mitigated by the diversification of sales. No single customer or group accounts for more than 10% of total revenue.
The Company maintained the following allowances for doubtful accounts on trade receivables:
2017 | 2016 | ||
Ipiranga | 238,697 | 182,252 | |
Ultragaz | 39,034 | 33,804 | |
Oxiteno | 10,755 | 10,856 | |
Extrafarma | 4,922 | 3,449 | |
Ultracargo | 2,172 | 2,971 | |
Total | 295,580 | 233,332 |
Liquidity Risk
The Company and its subsidiaries’ main sources of liquidity derive from (i) cash, cash equivalents, and financial investments, (ii) cash generated from operations and (iii) financing. The Company and its subsidiaries believe that these sources are sufficient to satisfy their current funding requirements, which include, but are not limited to, working capital, capital expenditures, amortization of debt, and payment of dividends.
The Company and its subsidiaries periodically examine opportunities for acquisitions and investments. They consider different types of investments, either directly, through joint ventures, or through associated companies, and finance such investments using cash generated from operations, debt financing, through capital increases, or through a combination of these methods.
The Company and its subsidiaries believe to have enough working capital and sources of financing to satisfy their current needs. The gross indebtedness due over the next twelve months totals R$ 3,809.9 million, including estimated interests on loans (for quantitative information, see Note 14). Furthermore, the investment plan for 2018 totals R$ 2,676 million. As of December 31, 2017, the Company and its subsidiaries had R$ 6,285.5 million in cash, cash equivalents, and short-term financial investments (for quantitative information, see Note 4).
The table below presents a summary of financial liabilities as of December 31, 2017 to be settled by the Company and its subsidiaries, listed by maturity. The amounts disclosed in this table are the contractual undiscounted cash outflows, and, therefore, these amounts may be different from the amounts disclosed on the balance sheet as of December 31, 2017.
In millions of Brazilian Reais | |||||||||
Financial liabilities | Total | Less than 1 year | Between 1 and 3 years | Between 3 and 5 years | More than 5 years | ||||
Loans including future contractual interest (1) (2) | 16,571.3 | 3,809.9 | 3,514.4 | 4,968.0 | 4,279.0 | ||||
Currency and interest rate hedging instruments (3) | 422.2 | 145.2 | 136.6 | 113.4 | 27.0 | ||||
Trade payables | 2,155.5 | 2,155.5 | - | - | - |
(1) To calculate the estimated interest on loans some macroeconomic assumptions were used, including averaging for the period the following: (i) CDI of 6.76% in 2018, 8.08% from 2019 to 2020, 9.63% from 2021 to 2022, 10.70% from 2023 to 2033, (ii) exchange rate of the Real against the U.S. dollar of R$ 3.37 in 2018, R$ 3.53 in 2019, R$ 3.77 in 2020, R$ 4.05 in 2021, R$ 4.35 in 2022, R$ 4.66 in 2023, R$ 4.99 in 2024, R$ 5.35 in 2025, R$ 5.73 in 2026 and R$ 6.13 in 2027 (iii) TJLP of 6.75% p.a. and (iv) IGP-M of 4.38% in 2018, 4.13% in 2019, 4.0% from 2020 to 2033 (v) IPCA of 3.9% (source: B3, Bulletin Focus and financial institutions).
(2) Includes estimated interest payments on short-term and long-term loans until the payment date.
(3) The currency and interest rate hedging instruments were estimated based on projected U.S dollar futures contracts and the futures curves of DI x Pre and Pre x IPCA contracts quoted on B3 on December 28, 2017 and on the futures curve of LIBOR (ICE - IntercontinentalExchange) on December 29, 2017. In the table above, only the hedging instruments with negative results at the time of settlement were considered.
Capital Management
The Company manages its capital structure based on indicators and benchmarks. The key performance indicators related to the capital structure management are the weighted average cost of capital, net debt / EBITDA, interest coverage, and indebtedness / equity ratios. Net debt is composed of cash, cash equivalents, and financial investments (see Note 4) and loans, including debentures (see Note 14). The Company can change its capital structure depending on the economic and financial conditions, in order to optimize its financial leverage and capital management. The Company seeks to improve its return on invested capital by implementing efficient working capital management and a selective investment program.
Selection and Use of Financial Instruments
In selecting financial investments and hedging instruments, an analysis is conducted to estimate rates of return, risks involved, liquidity, calculation methodology for the carrying value and fair value, and a review is conducted of any documentation applicable to the financial instruments. The financial instruments used to manage the financial resources of the Company and its subsidiaries are intended to preserve value and liquidity.
The Policy contemplates the use of derivative financial instruments only to cover identified risks and in amounts consistent with the risk (limited to 100% of the identified risk). The risks identified in the Policy are described in the above sections, and are subject to risk management. In accordance with the Policy, the Company and its subsidiaries can use forward contracts, swaps, options, and futures contracts to manage identified risks. Leveraged derivative instruments are not permitted. Because the use of derivative financial instruments is limited to the coverage of identified risks, the Company and its subsidiaries use the term “hedging instruments” to refer to derivative financial instruments.
As mentioned in the section “Risk Management and Financial Instruments – Governance”, the Committee monitors compliance with the risk standards established by the Policy through a risk map, including the use of hedging instruments, on a monthly basis. In addition, the internal audit department verifies the compliance with the requirements of the Policy.
The table below summarizes the position of hedging instruments entered into by the Company and its subsidiaries:
Notional amount1 | Fair value | Amounts receivable | Amounts payable | |||||||||
Hedging instruments | Maturity | 2017 | 2016 | 2017 | 2016 | 2017 | ||||||
R$ | R$ | R$ | R$ | |||||||||
million | million | million | million | |||||||||
a –Exchange rate swaps receivable in U.S. dollars | ||||||||||||
Receivables in U.S. dollars (LIBOR) | Jan 2018 to Oct 2026 | US$ 300.0 | US$ 350.0 | 984.3 | 1,149.7 | 984.3 | - | |||||
Receivables in U.S. dollars (Fixed) | US$ 956.6 | US$ 1,062.4 | 823.1 | 1,084.6 | 823.1 | - | ||||||
Payables in CDI interest rate | US$ (1,256.6) | US$ (1,412.4) | (1,877.4) | (2,181.6) | - | 1,877.4 | ||||||
Total result | - | - | (70.0) | 52.7 | 1,807.4 | 1,877.4 | ||||||
b – Exchange rate swaps payable in U.S. dollars + COUPON | Jan 2018 to Apr 2018 | |||||||||||
Receivables in CDI interest rates | US$ 9.1 | US$ 8.5 | 29.9 | 28.3 | 29.9 | - | ||||||
Payables in U.S. dollars (Fixed) | US$ (9.1) | US$ (8.5) | (29.8) | (27.9) | - | 29.8 | ||||||
Total result | - | - | 0.1 | 0.4 | 29.9 | 29.8 | ||||||
c – Interest rate swaps in Brazilian Reais | Oct 2024 | |||||||||||
Receivables in fixed interest rates + IPCA | R$ 566.1 | - | 583.3 | - | 583.3 | - | ||||||
Payables in CDI interest rates | R$ (566.1) | - | (586.6) | - | - | 586.6 | ||||||
Total result | - | - | (3.3) | - | 583.3 | 586.6 | ||||||
Total gross result | (73.2) | 53.1 | 2,420.6 | 2,493.8 | ||||||||
Income tax | (4.7) | (36.9) | (4.7) | - | ||||||||
Total net result | (77.9) | 16.2 | 2,415.9 | 2,493.8 | ||||||||
Positive result (see Note 4) | 85.8 | 218.5 | ||||||||||
Negative result (see Note 14) | (163.7) | (202.3) |
(1) In million. Currency as indicated.
All transactions mentioned above were properly registered with CETIP S.A.
Hedging instruments existing as of December 31, 2017 are described below, according to their category, risk, and hedging strategy:
a - Hedging against foreign exchange exposure of liabilities in foreign currency - The purpose of these contracts is (i) to offset the effect of the change in exchange rates of debts or firm commitments in U.S. dollars by converting them into debts or firm commitments in Brazilian Reais linked to CDI, (ii) firm commitments in U.S. dollars, changing them into debts or firm commitments in Reais indexed to the CDI and (iii) change a financial investment linked to the CDI and given as a guarantee to a loan in the U.S. dollar into a financial investment linked to the U.S. dollar. As of December 31, 2017, the Company and its subsidiaries had outstanding swap contracts totaling US$ 1,256.6 million in notional amount with a liability position, on average of 81.5% of CDI, of which US$ 223.6 million, had an asset position at US$ + 1.17% p.a., US$ 300.0 million had an asset position at US$ + LIBOR + 1.29% p.a. and US$ 733.0 million in interest rate swap with an asset position at US$ + 5.65% p.a. This amount includes US$ 320.0 million related to the fair value of hedging instruments of Ipiranga’s debt (see Notes 14.c and “hedge accounting” below) and US$ 115.0 million related to hedging instruments of cash flow of firm commitment (see “hedge accounting” below).
b - Hedging against foreign exchange exposure of operations - The purpose of these contracts is to make the exchange rate of the revenues of subsidiaries Oleoquímica, Oxiteno S.A. and Oxiteno Nordeste equal to the exchange rate of the cost of their main raw materials during their operating cycles. As of December 31, 2017, these swap contracts totaled US$ 9.1 million and, on average, had an asset position at 57.4% of CDI and a liability position at US$ + 0.0% p.a.
c - Hedging against fixed interest rate + IPCA in Brazilian Reais – The purpose of this contract is to change fixed interest rate + IPCA of debentures issued in Brazilian Reais to floating interest. As of December 31, 2017 this swap contract totaled R$ 566.1 million of notional amount, corresponding to the principal amount of the debt and had an asset position at 4.55% p.a. + IPCA and a liability position at 95.2% of CDI.
Hedge Accounting
The Company and its subsidiaries use derivative and non-derivative financial instruments for hedging purposes and test, throughout the duration of the hedge, their effectiveness, as well as the changes in their fair value.
Fair value hedge
The Company and its subsidiaries designate as fair value hedges certain financial instruments used to offset the variations in interest and exchange rates, which are based on the market value of financing contracted in Brazilian Reais and U.S. dollars.
On December 31, 2017, the notional amount of foreign exchange hedging instruments designated as fair value hedge totaled US$ 320.0 million. In 2017, a loss of R$ 143.4 million related to the result of hedging instruments, a gain of R$ 16.5 million related to the fair value adjustment of debt, and a loss of R$ 4.1 million related to the financial expense of the debt were recognized in the income statements, transforming the average effective cost of the operation into 102.7% of CDI (see Note 14.c.1).
On December 31, 2017, the notional amount of interest rate hedging instruments designated as fair value hedges totaled R$ 566.1 million. As of December 31, 2017, a loss of R$ 3.3 million related to the result of hedging instruments, a gain of R$ 19.1 million related to the fair value adjustment of debt, and a loss of R$ 18.5 million related to the financial expense of the debt were recognized in the income statements, transforming the average effective cost of the operations into 95.2% of CDI.
Cash flow hedge
The Company and its subsidiaries designate, as cash flow hedge of firm commitment and highly probable transactions, derivative financial instruments to hedge "firm commitments" and non-derivative financial instruments to hedge "highly probable future transactions", to hedge against fluctuations arising from changes in exchange rate.
On December 31, 2017, the notional amount of exchange rate hedging instruments of firm commitments designated as cash flow hedges totaled US$ 115.0 million, and a loss of R$ 45.4 million was recognized in the income statement. On December 31, 2017, the unrealized gain of “Other comprehensive income” is R$ 5.3 million (loss of R$ 13.8 million on December 31, 2016), net of deferred income and social contribution taxes.
On December 31, 2017, the notional amount of foreign exchange hedging instruments for highly probable future transactions designated as fair value hedge, related to notes in the foreign market totaled US$ 570.0 million. On December 31, 2017, the unrealized loss of “Other comprehensive income” is R$ 30.5 million (loss of R$ 12.1 million on December 31, 2016), net of deferred income and social contribution taxes.
Net investment hedge in foreign entities
The Company and its subsidiaries designate, as net investment hedge in foreign entities, notes in the foreign market, for hedging net investment in foreign entities, to offset changes in exchange rates.
On December 31, 2017, the balance of foreign exchange hedging instruments designated as net investments hedge in foreign entities, related to part of the investments made in entities which functional currency is other than the Brazilian Real, totaled US$ 113.0 million. On December 31, 2017, the unrealized loss of “Other comprehensive income” is R$ 6.2 million (loss of R$ 2.8 million on December 31, 2016), net of deferred income and social contribution taxes. The effects of exchange rate changes on investments and hedging instruments were offset in shareholders' equity.
Gains (losses) on Hedging Instruments
The following tables summarize the value of gains (losses) recognized, which affected the shareholders’ equity of the Company and its subsidiaries:
R$ million | |||
2017 | |||
Profit or loss | Equity | ||
a – Exchange rate swaps receivable in U.S. dollars (i) (ii) | (72.1) | 5.3 | |
b – Exchange rate swaps payable in U.S. dollars (ii) | 3.2 | - | |
c – Interest rate swaps in R$ (iii) | 15.9 | - | |
d – Non-derivative financial instruments (iv) | (104.2) | (36.7) | |
Total | (157.2) | (31.4) |
R$ million | ||||
2016 | 2016 | |||
Profit or loss | Equity | |||
a – Exchange rate swaps receivable in U.S. dollars (i) (ii) | (177.0) | (13.8) | ||
b – Exchange rate swaps payable in U.S. dollars (ii) | 9.2 | - | ||
c – Interest rate swaps in R$ (iii) | (0.5) | - | ||
d – Non-derivative financial instruments (iv) | (28.5) | (14.9) | ||
Total | (196.8) | (28.7) | ||
R$ million | |||
2015 | |||
Profit or loss | Equity | ||
a – Exchange rate swaps receivable in U.S. dollars (i) (ii) | (143.1) | 6.3 | |
b – Exchange rate swaps payable in U.S. dollars (ii) | (2.2) | (31.3) | |
c – Interest rate swaps in R$ (iii) | 1.1 | - | |
Total | (144.2) | (25.0) |
(i) Does not consider the effect of exchange rate variation of exchange swaps receivable in U.S. dollars when this effect is offset in the gain or loss of the hedged item (debt/firm commitments).
(ii) Considers the designation effect of foreign exchange hedging.
(iii) Considers the designation effect of interest rate hedging in Brazilian Reais.
(iv) Considers the results of notes in the foreign market.
Fair Value of Financial Instruments
The fair values and the carrying values of the financial instruments, including currency and interest rate hedging instruments, are stated below:
2017 | 2016 | ||||||||
Category |
Note |
Carrying value |
Fair value |
Carrying value |
Fair value | ||||
Financial assets: | |||||||||
Cash and cash equivalents | |||||||||
Cash and bank deposits | Loans and receivables | 4 | 147,926 | 147,926 | 113,318 | 113,318 | |||
Financial investments in local currency | Measured at fair value through profit or loss | 4 | 4,821,605 | 4,821,605 | 3,837,807 | 3,837,807 | |||
Financial investments in foreign currency | Measured at fair value through profit or loss |
4 |
32,473 | 32,473 | 323,033 | 323,033 | |||
Financial investments: | |||||||||
Fixed-income securities and funds in local currency | Available for sale | 4 | 68,742 | 68,742 | 113,640 | 113,640 | |||
Fixed-income securities and funds in local currency | Measured at fair value through profit or loss | 4 | 1,076,849 | 1,076,849 | 1,053,369 | 1,053,369 | |||
Fixed-income securities and funds in local currency | Held to maturity | 4 | 7,449 | 7,449 | 7,449 | 7,449 | |||
Fixed-income securities and funds in foreign currency | Available for sale |
4 |
129,131 | 129,131 | 34,775 | 34,775 | |||
Currency and interest rate hedging instruments |
Measured at fair value through profit or loss |
4 |
85,753 | 85,753 | 218,458 | 218,458 | |||
Total | 6,369,928 | 6,369,928 | 5,701,849 | 5,701,849 | |||||
Financial liabilities: | |||||||||
Financing | Measured at fair value through profit or loss |
14 |
1,047,809 | 1,047,809 | 1,428,907 | 1,428,907 | |||
Financing | Measured at amortized cost | 14 | 6,740,872 | 6,761,907 | 6,990,269 | 6,881,085 | |||
Debentures | Measured at amortized cost | 14 | 5,035,247 | 5,037,072 | 2,746,881 | 2,746,915 | |||
Debentures | Measured at fair value through profit or loss | 14 | 554,402 | 554,402 | - | - | |||
Finance leases | Measured at amortized cost | 14 | 48,515 | 48,515 | 48,716 | 48,716 | |||
Currency and interest rate hedging instruments | Measured at fair value through profit or loss |
14 |
163,749 | 163,749 | 202,357 | 202,357 | |||
Subscription warrants – indemnification | Measured at fair value through profit or loss | 22 | 171,459 | 171,459 | 153,429 | 153,429 | |||
Total | 13,762,053 | 13,784,913 | 11,570,559 | 11,461,409 |
The fair value of financial instruments, including currency and interest hedging instruments, was determined as follows:
• | The fair value of cash and bank deposit balances are identical to their carrying values. |
• | Financial investments in investment funds are valued at the value of the fund unit as of the date of the financial statements, which corresponds to their fair value. |
• | Financial investments in CDBs (Bank Certificates of Deposit) and similar investments offer daily liquidity through repurchase at the “yield curve” and, therefore, the Company believes their fair value corresponds to their carrying value. |
• | The fair value of trade receivables and trade payables are approximate to their carrying values. |
|
The subscription warrants – indemnification were measured based on the share price of Ultrapar (UGPA3) at the financial statements date and are adjusted to the Company’s dividend yield, since the exercise is only possible starting in 2020 onwards and they are not entitled to dividends until then. The number of shares of subscription warrants – indemnification is also adjusted according to the changes in the amounts of provision for tax, civil, and labor risks and contingent liabilities related to the period prior to January 31, 2014. (See Note 22). |
• | The fair value calculation of notes in the foreign market (see Note 14.b) is based on the quoted price in an active market. |
The fair value of other financial investments and financing was determined using calculation methodologies commonly used for mark-to-market reporting, which consist of calculating future cash flows associated with each instrument adopted and adjusting them to present value at the market rates as of December 31, 2017 and 2016. For some cases where there is no active market for the financial instrument, the Company and its subsidiaries can use quotes provided by the transaction counterparties.
The interpretation of market information on the choice of calculation methodologies for the fair value requires considerable judgment and estimates to obtain a value deemed appropriate to each situation. Consequently, the estimates presented do not necessary indicate the amounts that may be realizable in the current market.
Financial instruments were classified as loans and receivables or financial liabilities measured at amortized cost, except (i) all exchange rate and interest rate hedging instruments, which are measured at fair value through profit or loss, (ii) financial investments classified as measured at fair value through profit or loss, (iii) financial investments that are classified as available for sale, which are measured at fair value through other comprehensive income (see Note 4), (iv) loans and financing measured at fair value through profit or loss (see Note 14), (v) guarantees to customers that have vendor arrangements (see Note 14.k), which are measured at fair value through profit or loss, and (vi) subscription warrants – indemnification, which are measured at fair value through profit or loss (see Note 22). The financial investments classified as held-to-maturity are measured at amortized cost. Cash, banks, and trade receivables are classified as loans and receivables. Trade payables and other payables are classified as financial liabilities measured at amortized cost.
Fair Value Hierarchy of Financial Instruments
The financial instruments are classified in the following categories:
(a) | Level 1 - prices negotiated (without adjustment) in active markets for identical assets or liabilities; |
(b) | Level 2 - inputs other than prices negotiated in active markets included in Level 1 and observable for the asset or liability, either directly (as prices) or indirectly (derived from prices); and |
(c) | Level 3 - inputs for the asset or liability which are not based on observable market variables (unobservable inputs). |
The table below shows a summary of the financial assets and financial liabilities measured at fair value in the Company’s and its subsidiaries:
Category | Note | 2017 | Level 1 | Level 2 | Level 3 | |||||
Financial assets: | ||||||||||
Cash equivalents | ||||||||||
Cash and banks | Loans and receivables | 4 | 147,926 | 147,926 | - | - | ||||
Financial investments in local currency | Measured at fair value through profit or loss | 4 | 4,821,605 | 4,821,605 | - | - | ||||
Financial investments in foreign currency | Measured at fair value through profit or loss | 4 | 32,473 | 32,473 | - | - | ||||
Financial investments: | ||||||||||
Fixed-income securities and funds in local currency | Available for sale | 4 | 68,742 | 68,742 | - | - | ||||
Fixed-income securities and funds in local currency | Measured at fair value through profit or loss | 4 | 1,076,849 | 1,076,849 | - | - | ||||
Fixed-income securities and funds in local currency | Held to maturity | 4 | 7,449 | 7,449 | - | - | ||||
Fixed-income securities and funds in foreign currency | Available for sale | 4 | 129,131 | 40,556 | 88,575 | - | ||||
Currency and interest rate hedging instruments | Measured at fair value through profit or loss | 4 | 85,753 | - | 85,753 | - | ||||
Total | 6,369,928 | 6,195,600 | 174,328 | - | ||||||
Financial liabilities: | ||||||||||
Financing | Measured at fair value through profit or loss | 14 | 1,047,809 | - | 1,047,809 | - | ||||
Financing | Measured at amortized cost | 14 | 6,761,907 | 2,523,643 | 4,238,264 | - | ||||
Debentures | Measured at amortized cost | 14 | 5,037,072 | - | 5,037,072 | - | ||||
Debentures | Measured at fair value through profit or loss | 14 | 554,402 | - | 554,402 | - | ||||
Finance leases | Measured at amortized cost | 14 | 48,515 | - | 48,515 | - | ||||
Currency and interest rate hedging instruments | Measured at fair value through profit or loss | 14 | 163,749 | - | 163,749 | - | ||||
Subscription warrants – indemnification (1) | Measured at fair value through profit or loss | 22 | 171,459 | - | 171,459 | - | ||||
Total | 13,784,913 | 2,523,643 | 11,261,270 | - |
Category | Note | 2016 | Level 1 | Level 2 | Level 3 | |||||
Financial assets: | ||||||||||
Cash equivalents | ||||||||||
Cash and banks | Loans and receivables | 4 | 113,318 | 113,318 | - | - | ||||
Financial investments in local currency | Measured at fair value through profit or loss | 4 | 3,837,807 | 3,837,807 | - | - | ||||
Financial investments in foreign currency | Measured at fair value through profit or loss | 4 | 323,033 | 323,033 | - | - | ||||
Financial investments: | ||||||||||
Fixed-income securities and funds in local currency | Available for sale | 4 | 113,640 | 113,640 | - | - | ||||
Fixed-income securities and funds in local currency | Measured at fair value through profit or loss | 4 | 1,053,369 | 1,053,369 | - | - | ||||
Fixed-income securities and funds in local currency | Held to maturity | 4 | 7,449 | 7,449 | - | - | ||||
Fixed-income securities and funds in foreign currency | Available for sale | 4 | 34,775 | 32,167 | 2,608 | - | ||||
Currency and interest rate hedging instruments | Measured at fair value through profit or loss | 4 | 218,458 | - | 218,458 | - | ||||
Total | 5,701,849 | 5,480,783 | 221,066 | - | ||||||
Financial liabilities: | ||||||||||
Financing | Measured at fair value through profit or loss | 14 | 1,428,907 | - | 1,428,907 | - | ||||
Financing | Measured at amortized cost | 14 | 6,881,085 | 2,338,920 | 4,542,165 | - | ||||
Debentures | Measured at amortized cost | 14 | 2,746,915 | - | 2,746,915 | - | ||||
Finance leases | Measured at amortized cost | 14 | 48,716 | - | 48,716 | - | ||||
Currency and interest rate hedging instruments | Measured at fair value through profit or loss | 14 | 202,357 | - | 202,357 | - | ||||
Subscription warrants – indemnification (1) | Measured at fair value through profit or loss | 22 | 153,429 | - | 153,429 | - | ||||
Total | 11,461,409 | 2,338,920 | 9,122,489 | - |
(1) Refers to subscription warrants issued by the Company in the Extrafarma acquisition.
The fair value of trade receivables and trade payables are classified as level 2.
Sensitivity Analysis
The Company and its subsidiaries use derivative financial instruments only to hedge against identified risks and in amounts consistent with the risk (limited to 100% of the identified risk). Thus, for purposes of sensitivity analysis of market risks associated with financial instruments, the Company analyzes the hedging instrument and the hedged item together, as shown on the charts below.
For the sensitivity analysis of foreign exchange hedging instruments, management adopted as a likely scenario the Real/U.S. dollar exchange rates at maturity of each swap, projected by U.S dollar futures contracts quoted on B3 as of December 28, 2017. As a reference, the exchange rate for the last maturity of foreign exchange hedging instruments is R$ 5.83 in the likely scenario. Scenarios II and III were estimated with a 25% and 50% additional appreciation or depreciation of the Brazilian Real against the likely scenario, according to the risk to which the hedged item is exposed.
Based on the balances of the hedging instruments and hedged items as of December 29, 2017, the exchange rates were replaced, and the changes between the new balance in Brazilian Reais and the original balance in Brazilian Reais as of December 29, 2017 were calculated in each of the three scenarios. The table below shows the change in the values of the main derivative instruments and their hedged items, considering the changes in the exchange rate in the different scenarios:
Risk | Scenario I (likely) | Scenario II | Scenario III | ||||
Currency swaps receivable in U.S. dollars | |||||||
(1) U.S. Dollar / Real swaps | Dollar | 198,138 | 690,432 | 1,182,726 | |||
(2) Debts/firm commitments in dollars | appreciation | (198,130) | (690,415) | (1,182,700) | |||
(1)+(2) | Net effect | 8 | 17 | 26 | |||
Currency swaps payable in U.S. dollars | |||||||
(3) Real / U.S. Dollar swaps | Dollar | (97) | 7,486 | 15,069 | |||
(4) Gross margin of Oxiteno | devaluation | 97 | (7,486) | (15,069) | |||
(3)+(4) | Net effect | - | - | - |
For sensitivity analysis of hedging instruments for interest rates in Brazilian Reais, the Company used the futures curve of the DI x Pre contract quoted on B3 as of December 28, 2017 for each of the swap and debt (hedged item) maturities, to determine the likely scenarios. Scenarios II and III were estimated based on a 25% and 50% deterioration, respectively, of the likely scenario pre-fixed interest rate.
Based on the three scenarios of interest rates in Brazilian Reais, the Company estimated the values of its debt and hedging instruments according to the risk which is being hedged (variations in the pre-fixed interest rates in Brazilian Reais), by projecting them to future value at the contracted rates and bringing them to present value at the interest rates of the estimated scenarios. The result are shown in the table below:
Risk | Scenario I (likely) | Scenario II | Scenario III | ||||
Interest rate swap (in Brazilian Reais) – Debentures - CRA | |||||||
(1) Fixed rate swap - CDI | Decrease in | 13,691 | 95,292 | 192,204 | |||
(2) Fixed rate debt | Pre-fixed rate | (13,691) | (95,292) | (192,204) | |||
(1) + (2) | Net effect | - | - | - |